Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0038362 (
stomatitis
)
8,852
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Transcriptional activation of cytokines, such as type-I interferons (interferon (IFN)-alpha and IFN-beta), constitutes the first line of antiviral defence. Here we show that translational control is critical for induction of type-I IFN production. In mouse embryonic fibroblasts lacking the translational repressors 4E-BP1 and
4E-BP2
, the threshold for eliciting type-I IFN production is lowered. Consequently, replication of encephalomyocarditis virus, vesicular
stomatitis
virus, influenza virus and Sindbis virus is markedly suppressed. Furthermore, mice with both 4E- and
4E-BP2
genes (also known as Eif4ebp1 and Eif4ebp2, respectively) knocked out are resistant to vesicular
stomatitis
virus infection, and this correlates with an enhanced type-I IFN production in plasmacytoid dendritic cells and the expression of IFN-regulated genes in the lungs. The enhanced type-I IFN response in 4E-BP1-/-
4E-BP2
-/- double knockout mouse embryonic fibroblasts is caused by upregulation of interferon regulatory factor 7 (Irf7) messenger RNA translation. These findings highlight the role of 4E-BPs as negative regulators of type-I IFN production, via translational repression of Irf7 mRNA.
...
PMID:Translational control of the innate immune response through IRF-7. 1827 64
Genetic deletion of both 4E-BP1 and
4E-BP2
was found to protect cells against viral infections. Here we demonstrate that the individual loss of either 4E-BP1 or
4E-BP2
in mouse embryonic fibroblasts (MEFs) is sufficient to confer viral resistance. shRNA-mediated silencing of 4E-BP1 or
4E-BP2
renders MEFs resistant to viruses, and compared to wild type cells, MEFs knockout for either 4E-BP1 or
4E-BP2
exhibit enhanced translation of Irf-7 and consequently increased innate immune response to viruses. Accordingly, the replication of vesicular
stomatitis
virus, encephalomyocarditis virus, influenza virus and Sindbis virus is markedly suppressed in these cells. Importantly, expression of either 4E-BP1 or
4E-BP2
in double knockout or respective single knockout cells diminishes their resistance to viral infection. Our data show that loss of 4E-BP1 or
4E-BP2
potentiates innate antiviral immunity. These results provide further evidence for translational control of innate immunity and support targeting translational effectors as an antiviral strategy.
...
PMID:Deficiency in either 4E-BP1 or 4E-BP2 augments innate antiviral immune responses. 2553 41